Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 3Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Somatostatinoma 1Sarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteosarcoma 1Mesothelioma, Malignant 1Meningioma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Insulinoma 1Immunoblastic Lymphadenopathy 1Glucagonoma 1

Interventions

Paclitaxel 3Docetaxel 3Watchful Waiting 2Tamoxifen 2Immunohistochemistry 2Goserelin 2Everolimus 2Cyclophosphamide 2Bevacizumab 2Anastrozole 2vandetanib 1pegfilgrastim 1lonafarnib 1exemestane 1Trastuzumab 1Sunitinib 1Psychiatric Rehabilitation 1Neoadjuvant Therapy 1Metformin 1Mental Status and Dementia Tests 1Leuprolide 1Letrozole 1Lapatinib 1High-Energy Shock Waves 1Gene Expression Profiling 1Doxorubicin 1Dasatinib 1Chemotherapy, Adjuvant 1Biopsy, Needle 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms, Male × Everolimus × Clear all
NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00255788 2023-08-04

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 2 Completed
49 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡